Literature DB >> 19012686

Correlation between Braden Scale and Palliative Performance Scale in advanced illness.

Vincent Maida1, Francis Lau, Michael Downing, Ju Yang.   

Abstract

This study describes the significant correlation between the Braden Scale (BS) and the Palliative Performance Scale (PPS) in patients with advanced illness that has not been previously reported. The analysis was based on a prospective sequential case series of 664 patients suffering from advanced illness who were referred to a regional palliative medicine programme in Toronto, Canada. Baseline BS and PPS scores assessed within 24 hours of referral were considered for analysis. After controlling for age, gender, consult site and diagnosis (cancer versus non cancer), we observed a significant positive correlation between baseline PPS and BS scores (r = 0.885, P < 0.001). These findings suggest that for patients with advanced illness where BS is not routinely used, PPS could be considered as a proxy for pressure ulcer risk assessment.

Entities:  

Mesh:

Year:  2008        PMID: 19012686      PMCID: PMC7951379          DOI: 10.1111/j.1742-481X.2008.00475.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  12 in total

1.  Predictors of short-term functional decline in survivors of nursing home-acquired lower respiratory tract infection.

Authors:  Ellen F Binder; Robin L Kruse; Ashley K Sherman; Richard Madsen; Steven C Zweig; Ralph D'Agostino; David R Mehr
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-01       Impact factor: 6.053

Review 2.  Preventing pressure ulcers with the Braden scale: an update on this easy-to-use tool that assesses a patient's risk.

Authors:  Barbara J Braden; JoAnn Maklebust; Joann Maklebust
Journal:  Am J Nurs       Date:  2005-06       Impact factor: 2.220

3.  Would you refer this patient to hospice? An evaluation of tools for determining life expectancy in end-stage dementia.

Authors:  Danielle J Doberman; Sevil Yasar; Samuel C Durso
Journal:  J Palliat Med       Date:  2007-12       Impact factor: 2.947

Review 4.  Risk assessment scales for pressure ulcer prevention: a systematic review.

Authors:  Pedro L Pancorbo-Hidalgo; Francisco Pedro Garcia-Fernandez; Isabel Ma Lopez-Medina; Carmen Alvarez-Nieto
Journal:  J Adv Nurs       Date:  2006-04       Impact factor: 3.187

5.  Palliative performance scale (PPS): a new tool.

Authors:  F Anderson; G M Downing; J Hill; L Casorso; N Lerch
Journal:  J Palliat Care       Date:  1996       Impact factor: 2.250

6.  Air-fluidized bed treatment of nursing home patients with pressure sores.

Authors:  R G Bennett; M F Bellantoni; J G Ouslander
Journal:  J Am Geriatr Soc       Date:  1989-03       Impact factor: 5.562

7.  Home versus hospice inpatient care: discharge characteristics of palliative care patients in an acute care hospital.

Authors:  R L Fainsinger; D Demoissac; J Cole; K Mead-Wood; E Lee
Journal:  J Palliat Care       Date:  2000       Impact factor: 2.250

8.  Clinical utility of the Braden scale for Predicting Pressure Sore Risk.

Authors:  B J Braden; N Bergstrom
Journal:  Decubitus       Date:  1989-08

9.  End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.

Authors:  Luísa Lobato; Idalina Beirão; Manuela Silva; Isabel Fonseca; José Queirós; Guilherme Rocha; António Morais Sarmento; Alda Sousa; Jorge Sequeiros
Journal:  Amyloid       Date:  2004-03       Impact factor: 7.141

10.  Meta-analysis of survival prediction with Palliative Performance Scale.

Authors:  Michael Downing; Francis Lau; Mary Lesperance; Nicholas Karlson; Jack Shaw; Craig Kuziemsky; Steve Bernard; Laura Hanson; Lola Olajide; Barbara Head; Christine Ritchie; Joan Harrold; David Casarett
Journal:  J Palliat Care       Date:  2007       Impact factor: 2.250

View more
  1 in total

1.  Do pressure ulcer risk assessment scales improve clinical practice?

Authors:  Jan Kottner; Katrin Balzer
Journal:  J Multidiscip Healthc       Date:  2010-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.